Stocks
Vistagen Therapeutics, Inc.VTGN
NASDAQHealthcareBiotechnology$0.18
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing cell-based therapies for degenerative diseases, with a focus on neurological and ocular conditions. Its lead programs use proprietary technology to deliver therapeutic proteins directly to affected tissues, positioning it as a speculative play in the regenerative medicine space. Investors track VTGN for its pipeline milestones and potential partnerships, though the company has yet to generate product revenue.
52W Range: $0.17-$5.14
Congressional Interest in Vistagen Therapeutics, Inc. (VTGN)
No congressional trades have been disclosed for Vistagen Therapeutics, Inc. (VTGN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading VTGN?
No congressional trades found for this stock.